Inspire Medical Systems (INSP) Liabilities and Shareholders Equity (2017 - 2026)

Inspire Medical Systems has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $911.4 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 24.71% year-over-year to $911.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 billion (up 11.91% YoY) and the FY2025 annual result came in at $907.3 million, up 12.24% from the prior year.
• Liabilities and Shareholders Equity was little changed at $911.4 million in Q1 2026 per INSP's latest filing, from $907.3 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $911.4 million in Q1 2026 and troughed at $289.7 million in Q1 2022.
• A 5-year average of $668.2 million and a median of $685.8 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity surged 111.73% in 2023, then grew 1.45% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $564.9 million in 2022, then climbed by 19.82% to $676.8 million in 2023, then increased by 19.44% to $808.4 million in 2024, then advanced by 12.24% to $907.3 million in 2025, then grew by 0.45% to $911.4 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $911.4 million, $907.3 million, and $807.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.